Kite, a Gilead Company , announced results today from four analyses that continue to demonstrate the durability of response of Tecartus® (brexucabtagene autoleucel) in patients with ...

The Antarctic Peninsula is experiencing rapid warming, increasing air and sea temperatures, and changes in precipitation patterns (Vaughan et al. 2003). These changes have significant implications for ...